Long-term pharmacological therapy of Brugada syndrome: Is J-wave attenuation a marker of drug efficacy?

Internal Medicine

Volumn 53, Issue 14, 2014, Pages 1523-1526

  Hasegawa, Kanae ^a,b   Ashihara, Takashi ^a   Kimura, Hiromi ^a   Jo, Hikari ^a   Itoh, Hideki ^a   Yamamoto, Takashi ^a   Aizawa, Yoshifusa ^b,c   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c Tachikawa Medical Center General Hospital   (Japan)

Author keywords

Brugada syndrome; Cilostazol; J wave syndrome; Pharmacological therapy; Quinidine; Ventricular fibrillation

Indexed keywords

CILOSTAZOL; CLOPIDOGREL; PILSICAINIDE; QUINIDINE; ANTIARRHYTHMIC AGENT; PHOSPHODIESTERASE III INHIBITOR; TETRAZOLE DERIVATIVE;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DRUG EFFICACY; DRUG SUBSTITUTION; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FAINTNESS; FOLLOW UP; HEART RATE; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; J WAVE; LACUNAR STROKE; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POTASSIUM CURRENT; SINUS RHYTHM; ST SEGMENT ELEVATION; CONGENITAL MALFORMATION; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION SYSTEM; PATHOPHYSIOLOGY; TIME;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; BRUGADA SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE 3 INHIBITORS; QUINIDINE; TETRAZOLES; TIME FACTORS;

EID: 84904305607     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.1829     Document Type: Article

References (15)

1. Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J 76: 1054-1065, 2012.
2. Shu J, Zhu T, Yang L, Cui C, Yan GX. ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage. J Electrocardiol 38: 26-32, 2005.
3. Haissaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 358: 2016-2023, 2008.
4. Nam GB, Kim YH, Antzelevitch C. Augmentation of J waves and electrical storms in patients with early repolarization. N Engl J Med 358: 2078-2079, 2008.
5. Haissaguerre M, Sacher F, Nogami A, et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 53: 612-619, 2009.
6. Aizawa Y, Chinushi M, Hasegawa K, et al. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol 62: 1015-1019, 2013.
7. Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol 32: 294-301, 2009.
8. Viskin S, Antzelevitch C, Marquez MF, Belhassen B. Quinidine: a valuable medication joins the list of 'endangered species'. Europace 9: 1105-1106, 2007.
9. Tsuchiya T, Ashikaga K, Honda T, Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 13: 698-701, 2002.
10. Iguchi K, Noda T, Kamakura S, Shimizu W. Beneficial effects of cilostazol in a patient with recurrent ventricular fibrillation associated with early repolarization syndrome. Heart Rhythm 10: 604-606, 2013.
11. Aizawa Y, Sato A, Watanabe H, et al. Dynamicity of the J-wave in idiopathic ventricular fibrillation with a special reference to pausedependent augmentation of the J-wave. J Am Coll Cardiol 59: 1948-1953, 2012.
12. Chinushi M, Hasegawa K, Iijima K, et al. Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs. Pacing Clin Electrophysiol 35: e226-e230, 2012.
13. Ohgo T, Okamura H, Noda T, et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4: 695-700, 2007.
14. Kamakura S, Ohe T, Nakazawa K, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2: 495-503, 2009.
15. Kawata H, Morita H, Yamada Y, et al. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Heart Rhythm 10: 1161-1168, 2013.